These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3312552)

  • 1. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin.
    Krueger E; Mellander M; Bratton D; Cotton R
    J Pediatr; 1987 Nov; 111(5):749-54. PubMed ID: 3312552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.
    Couser RJ; Ferrara TB; Wright GB; Cabalka AK; Schilling CG; Hoekstra RE; Payne NR
    J Pediatr; 1996 May; 128(5 Pt 1):631-7. PubMed ID: 8627434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants.
    Lai TH; Soong WJ; Hwang B
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(1):17-23. PubMed ID: 2278224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.
    Bandstra ES; Montalvo BM; Goldberg RN; Pacheco I; Ferrer PL; Flynn J; Gregorios JB; Bancalari E
    Pediatrics; 1988 Oct; 82(4):533-42. PubMed ID: 3174314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic indomethacin in extremely premature infants between 23 and 24 weeks gestation.
    Yoshimoto S; Sakai H; Ueda M; Yoshikata M; Mizobuchi M; Nakao H
    Pediatr Int; 2010 Jun; 52(3):374-7. PubMed ID: 19843236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral indomethacin for closure of the patent ductus arteriosus. Clinical experience with 67 preterm infants.
    Harris JP; Merritt TA; Alexson CG; Longfield L; Manning JA
    Am J Dis Child; 1982 Nov; 136(11):1005-8. PubMed ID: 7124692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
    Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
    JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.
    Fowlie PW; Davis PG
    Cochrane Database Syst Rev; 2002; (3):CD000174. PubMed ID: 12137607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic treatment of asymptomatic patent ductus arteriosus in premature infants with respiratory distress syndrome.
    Weesner KM; Dillard RG; Boyle RJ; Block SM
    South Med J; 1987 Jun; 80(6):706-8. PubMed ID: 3296225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.
    Grosfeld JL; Chaet M; Molinari F; Engle W; Engum SA; West KW; Rescorla FJ; Scherer LR
    Ann Surg; 1996 Sep; 224(3):350-5; discussion 355-7. PubMed ID: 8813263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants].
    Vogtmann C; Grubbe G; Ruckhäberle KE; Böttcher H; Ockert C
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):636-9. PubMed ID: 3070369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.